A Study of LOXO-260 in Cancer Patients With a Change in a Particular Gene (RET) That Has Not Responded to Treatment
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- PHASE1
Clinical Trials Related to Eli Lilly and Company
Related studies linked through entity extraction aliases.
Janus Kinase-STAT Inhibition to Reduce APOL1 Associated Kidney Disease
- Status
- COMPLETED
- Phase
- PHASE2
Expanded Access for LOXO-260 in Participants With Cancer Caused by an Abnormal RET Gene That Did Not Respond/is no Longer Responding to Treatment With a Type of Drug Called a RET Inhibitor
- Status
- NO_LONGER_AVAILABLE
- Phase
- N/A
A Study of LY3871801 in Healthy Participants
- Status
- COMPLETED
- Phase
- PHASE1
A Study of Encorafenib Plus Cetuximab Taken Together With Pembrolizumab Compared to Pembrolizumab Alone in People With Previously Untreated Metastatic Colorectal Cancer
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- PHASE2
Study of the Effects of Itraconazole and Carbamazepine on LY3410738 in Healthy Participants
- Status
- TERMINATED
- Phase
- PHASE1
Chronic Pain Master Protocol (CPMP): A Study of LY3526318 in Participants With Diabetic Peripheral Neuropathic Pain
- Status
- COMPLETED
- Phase
- PHASE2
A Drug Drug Interaction (DDI) Study of Pirtobrutinib (LY3527727) and Rosuvastatin in Healthy Participants
- Status
- COMPLETED
- Phase
- PHASE1
Abemaciclib (LY2835219) Plus Fulvestrant Compared to Placebo Plus Fulvestrant in Previously Treated Breast Cancer
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- PHASE3
A Study of Evorpacept (ALX148) With Cetuximab and Pembrolizumab for Refractory Microsatellite Stable Metastatic Colorectal Cancer
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- PHASE2
A Study of Two Formulations (Both Refrigerated and Room Temperature) Using an Autoinjector Device in Healthy Participants
- Status
- COMPLETED
- Phase
- PHASE1
A Relative Bioavailability Study of Selpercatinib (LY3527723) in Healthy Participants
- Status
- COMPLETED
- Phase
- PHASE1
A Study of Galcanezumab (LY2951742) in Adult Participants With Episodic Migraine
- Status
- COMPLETED
- Phase
- PHASE4
A IMMA Master Protocol: A Study of LY3361237 in Participants With at Least Moderately Active Systemic Lupus Erythematosus
- Status
- TERMINATED
- Phase
- PHASE2
Abemaciclib Before 177Lu-PSMA-617 for the Treatment of Metastatic Castrate Resistant Prostate Cancer
- Status
- RECRUITING
- Phase
- PHASE1/PHASE2
A Multiple-Dose Study of LY3502970 in Healthy Participants
- Status
- COMPLETED
- Phase
- PHASE1
A Study of Donanemab (LY3002813) Compared With Aducanumab in Participants With Early Symptomatic Alzheimer's Disease (TRAILBLAZER-ALZ 4)
- Status
- COMPLETED
- Phase
- PHASE3
A Study Comparing Two Formulations of Selpercatinib (LY3527723) in Healthy Participants
- Status
- COMPLETED
- Phase
- PHASE1
A Study of LY3502970 in Japanese Participants With Type 2 Diabetes Mellitus
- Status
- COMPLETED
- Phase
- PHASE1
Chronic Pain Master Protocol (CPMP): A Study of LY3526318 in Participants With Chronic Low Back Pain
- Status
- COMPLETED
- Phase
- PHASE2